InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Friday, 10/25/2013 1:15:16 PM

Friday, October 25, 2013 1:15:16 PM

Post# of 695
Sell-side adjusts BioMarin targets after earnings • 11:15 AM

Below is a roundup of purported analyst price target changes for BioMarin (BMRN -3.5%) post-earnings.

Barclays raises target to $75 from $70.
Jefferies lowers target to $83 from $86.
Wells Fargo increases target range to $72-77.
Leerink hikes target to $76 from $72.

More: BMRN Q3 report, highlights, CC transcript

BMRN
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMRN News